High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$0
$0
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| COEP |
Coeptis Therapeutics Holdings, Inc.
|
Director
Other
|
2026-02-11 | $60,192 | M | Form 4 |
| COEP |
Coeptis Therapeutics Holdings, Inc.
|
Director
Other
|
2026-02-11 | $60,192 | M | Form 4 |
|
COEP
M
Coeptis Therapeutics Holdings, Inc.
Sheehy Christine Elise
• Officer • VP Compliance and Secy
Other
2026-02-11
$10,560
|
||||||
| COEP |
Coeptis Therapeutics Holdings, Inc.
|
Officer • VP Compliance and Secy
Other
|
2026-02-11 | $10,560 | M | Form 4 |
|
COEP
M
Coeptis Therapeutics Holdings, Inc.
Cochran Christopher P.
• Director
Other
2026-02-11
$60,192
|
||||||
| COEP |
Coeptis Therapeutics Holdings, Inc.
|
Director
Other
|
2026-02-11 | $60,192 | M | Form 4 |
| COEP |
Coeptis Therapeutics Holdings, Inc.
|
Director
Other
|
2026-02-11 | $60,192 | M | Form 4 |
|
COEP
M
Coeptis Therapeutics Holdings, Inc.
Yerace Daniel Alexander
• Officer • VP Operations
Other
2026-02-11
$104,100
|
||||||
| COEP |
Coeptis Therapeutics Holdings, Inc.
|
Officer • VP Operations
Other
|
2026-02-11 | $104,100 | M | Form 4 |
| COEP |
Coeptis Therapeutics Holdings, Inc.
|
CEO
Other
|
2026-02-11 | $1,049,569Large | M | Form 4 |
| COEP |
Coeptis Therapeutics Holdings, Inc.
|
Director
Other
|
2026-02-11 | $60,192 | M | Form 4 |
| COEP |
Coeptis Therapeutics Holdings, Inc.
|
CFO
Other
|
2026-02-11 | $105,600 | M | Form 4 |